Zubsolv is a Sublingual Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Orexo Us, Inc.. The primary component is Buprenorphine Hydrochloride; Naloxone Hydrochloride.
| Product ID | 54123-114_568c06d0-5a40-4a95-aff6-08c8af8bb6f9 |
| NDC | 54123-114 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zubsolv |
| Generic Name | Buprenorphine Hydrochloride And Naloxone Hydrochloride |
| Dosage Form | Tablet, Orally Disintegrating |
| Route of Administration | SUBLINGUAL |
| Marketing Start Date | 2014-12-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204242 |
| Labeler Name | Orexo US, Inc. |
| Substance Name | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
| Active Ingredient Strength | 11 mg/1; mg/1 |
| Pharm Classes | Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2014-12-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204242 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-12-11 |
| Ingredient | Strength |
|---|---|
| BUPRENORPHINE HYDROCHLORIDE | 11.4 mg/1 |
| SPL SET ID: | 5f5cfcfe-d52b-49e6-8fe4-550477332dd2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 54123-114 | Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride |
| 54123-907 | Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride |
| 54123-914 | Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride |
| 54123-929 | Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride |
| 54123-957 | Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride |
| 54123-986 | Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride |
| 50383-287 | Buprenorphine and Naloxone | buprenorphine hydrochloride and naloxone hydrochloride |
| 50383-294 | Buprenorphine and Naloxone | buprenorphine hydrochloride and naloxone hydrochloride |
| 53217-138 | Buprenorphine and Naloxone | buprenorphine hydrochloride and naloxone hydrochloride |
| 60429-586 | Buprenorphine and Naloxone | buprenorphine hydrochloride and naloxone hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZUBSOLV 79279822 not registered Live/Pending |
Orexo AB 2019-11-29 |
![]() ZUBSOLV 79279802 not registered Live/Pending |
Orexo AB 2019-11-29 |
![]() ZUBSOLV 79130980 4549698 Live/Registered |
Orexo AB 2013-04-15 |
![]() ZUBSOLV 79111641 4307243 Live/Registered |
Orexo AB 2012-03-29 |